ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging and rheumatoid arthritis (RA)"

  • Abstract Number: 1459 • 2018 ACR/ARHP Annual Meeting

    Bone Erosion Volume Changes Measured By HR-pQCT at 3-Months after Initiation of Anti-TNF Treatment Predicted Erosion Volume Changes at 1-Year in RA

    Tomohiro Shimizu1, Kenji Mamoto1, Matthew Tanaka1, Andrew J Burghardt2, Thomas Link1, Jonathan Graf3, John B. Imboden Jr.3 and Xiaojuan Li1, 1Radiology and Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, University of California, San Francisco, San Francisco, CA, 2Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, University of California, San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Bone erosions and joint space narrowing (JSN) are significant aspects of structural damage in rheumatoid arthritis. High resolution peripheral quantitative computed tomography (HR-pQCT) allows…
  • Abstract Number: 2206 • 2018 ACR/ARHP Annual Meeting

    Joint Repair While Initiating Biologic Therapy in Rheumatoid Arthritis

    Scott Brunet1,2,3, Sarah Manske1,2,3, Klaus Engelke4,5, Steven K. Boyd1,2,3 and Cheryl Barnabe2,6, 1Biomedical Engineering, University of Calgary, Calgary, AB, Canada, 2McCaig Institute for Bone and Joint Health, Calgary, AB, Canada, 3Department of Radiology, University of Calgary, Calgary, AB, Canada, 4Institute of Medical Physics, University of Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany, 5Department of Medicine, Erlangen University Hospital, Erlangen, Germany, 6Division of Rheumatology, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Functional decline and reduced quality of life for patients with rheumatoid arthritis (RA) results from chronic changes to joints in patients, including bone erosions…
  • Abstract Number: 247 • 2017 ACR/ARHP Annual Meeting

    Near Infrared Indocyanine Green Imaging Reveals Diminished Flow in Basilic Associated Lymphatic Vessels in the Hands of Rheumatoid Arthritis Patients during Flare

    Richard Bell1, Alicia Lieberman2, Ronald Wood3, Cristy Bell4, Homaira Rahimi5, Edward Schwarz6 and Christopher T. Ritchlin7, 1Orthopedics, University of Rochaester, Rochester, NY, 2Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 3University of Rochester, Rochester, NY, 4Allergy, Immunology & Rheumatology, University of Rochester, Rochester, NY, 5Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY, 6Orthopedeatrics, University of Rochester, Rochester, NY, 7Division of Allergy, Immunology and Rheumatology, School of Medicine and Dentistry, Division of Allergy, Immunology and Rheumatology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA, Rochester, NY

    Background/Purpose: Near infrared (NIR) imaging studies of subdermal indocyanine green (ICG) in murine models of inflammatory arthritis established the important contribution of lymphatic vessel (LV)…
  • Abstract Number: 1273 • 2016 ACR/ARHP Annual Meeting

    Effect of Anti-Cyclic Citrullinated Protein Antibodies and Rheumatoid Factor on Bone Erosions in Early Rheumatoid Arthritis Patients Using HR-pQCT: A Cross-Sectional Study

    JIANG YUE1, James F Griffith2, Lin Shi3, Defeng Wang2, Jiayun Shen4, Priscilla Wong5, Edmund LI5, Martin Li6, Tena K. Li6, Tracy Y. Zhu7, Ling qin8 and Lai-Shan TAM9, 1The Prince of Wales Hospital, The Chinese University of Hong Kong, Department of Medicine and Therapeutics, HONG KONG, Hong Kong, 2The Prince of Wales Hospital, The Chinese University of Hong Kong, Department of Imaging and Interventional Radiology, HONGKONG, Hong Kong, 3Department of Medicine & Therapeutics, Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, 4Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, China, 5Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 6Department Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China, 7Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong, China, 8Department of Orthopedics & Traumatology, hongkong, Hong Kong, 9Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: Concomitant presence of anti-cyclic citrullinated peptide antibodies (ACPA) and rheumatoid factor (RF) is associated with higher erosive disease burden in patients with established rheumatoid…
  • Abstract Number: 1178 • 2014 ACR/ARHP Annual Meeting

    Novel Quantification of MRI Provides a More Sensitive Outcome Measure Than Ramris

    Michael A. Bowes1, Gwenael Guillard1, Eleanor Gill1, Graham R. Vincent1, Elizabeth Hensor2, Jane E. Freeston3,4, Edward M. Vital4, P. Bird5, Paul Emery4 and Philip G. Conaghan6, 1Imorphics Ltd, Manchester, United Kingdom, 2NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom, 4NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds., United Kingdom, Leeds, United Kingdom, 5Combined Rheumatology Practice, Sydney, Australia, 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, United Kingdom

    Background/Purpose  There is increasing need for sensitive, objective outcome measures in rheumatoid arthritis (RA). MRI is more sensitive than clinical examination and X-rays, using a…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology